Apimeds Pharmaceuticals US, Inc. (APUS) › Net IncomeApimeds Pharmaceuticals US, Inc. (APUS) — Net IncomeAnnual figures by fiscal year, from SEC filings.2023: -$777.7K2024: -$1.39M2025: -$6.00M-$6.00M2023Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$6.00M-331.7%2024-$1.39M-78.7%2023-$777.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share